Bladder Cancer Diagnosis and Clinical Management

Bladder Cancer: Diagnosis and Clinical Management is a 100% clinically–focused guide to bladder cancer, providing practical, modern and evidence–based guidance to the latest in diagnosis and management of the condition. It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science. As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult.

In addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its various stages. Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient. A key addition is the final section dedicated to optimizing health care delivery, featuring chapters on highly topical issues such as quality of life, patient advocacy and surgical education.

Full color throughout, and packed with excellent images, each chapter contains concise and didactic practical tips and tricks to enrich the reading experience, in addition to management algorithms and the very latest guidelines from the ASCO, AUA, ESMO and EAU concerning clinical management of bladder cancer.

Part I: Diagnosis and Treatment of Non–Muscle Invasive Bladder Cancer

1 Pathology
Hikmat Al–Ahmadie, Donna E. Hansel

2 Risk Stratification of High–grade Ta, Cis and T1 UrothelialCarcinoma of the Bladder
Tobias Klatte, Fred Witjes, Gary Steinberg, Shahrokh F.Shariat

3 Utility of Urine Biomarkers
Derya Tilki, Alexandre R. Zlotta

4 Novel Endoscopic Techniques for the Detection of Bladder Cancer
Ayman Soubra, Joseph C. Liao, Badrinath Konety

5 Transurethral Resection of Bladder Tumors
Jen–Jane Liu, Mark P. Schoenberg

6 Intravesical Chemotherapy
Levent N. Türkeri, M. Guillaume Wientjes, Jessie L.S. Au

7 Intravesical Immunotherapy
Nilay M. Gandhi, Laura A. Bertrand, Donald L. Lamm, Michael A. O Donnell

8 HGT1 Bladder Cancer: Diagnosis and Treatment
J.M. Gaya, J. Palou, Edward M. Messing

9 What To Do When Bacillus Calmette–Guerin Fails
Massimiliano Spaliviero, Guido Dalbagni, Matthew Nielsen

Part II: T2–4

10 Selection and Peri–operative Management of Patients Undergoing Radical Cystectomy and Urinary Reconstruction
Robert S. Svatek, Alon Z. Weizer

11 Radical Cystectomy: Techniques and Outcomes
Siamak Daneshmand, Seth P. Lerner

12 Cystectomy in the Female Patient
Ryan Werntz, Georgios Gakis, Theresa Koppie, Arnulf Stenzl

13 Laparoscopic/Robotic Radical Cystectomy and Urinary Diversion: Outcomes
Kristina Wittig, Kevin Chan, Mark Kawachi, Timothy G.Wilson

14 Robotic Assisted Radical Cystectomy and Urinary Diversion: Clinical Trials
George J.S. Kallingal, Angela B. Smith, Raj S. Pruthi, Dipen J. Parekh

15 Role of Extended Lymphadenectomy
Eugene K. Cha, George N. Thalmann, Bernard H.Bochner

16 Management of the Urethra in the Cystectomy Patient
Kamal S. Pohar, Norm D. Smith

17 The Role of Radical Cystectomy in Patients with Unresectableor Regionally Metastatic Urothelial Carcinoma of the Bladder
Scott Delacroix, Jr, Nathan Lawrentschuk, and Ashish M.Kamat

Part III: Primary Bladder Sparing Therapy

18 Radical Transurethral Resection
Eduardo Solsona, Harry W. Herr

19 Partial Cystectomy
Ahmed Haddad, Yair Lotan, Arthur I. Sagalowsky

20 Integrating Chemotherapy and Radiotherapy for Bladder Cancer
Lior Z. Braunstein, William U. Shipley, Nicholas D. James, Andrea B. Apolo, Jason A. Efstathiou

Part IV: Urinary Tract Reconstruction

21 Orthotopic Neobladder
Eila C. Skinner

22 Continent Cutaneous Diversion
Andreas Neisius, Joachim W. Thüroff

23 Non–continent Urinary Diversion
Michael Rink, Fredrik Liedberg, Margit Fisch

Part V: Treatment of Regionally Advanced and Metastatic Bladder Cancer

24 Molecular Determinants of Chemotherapy Response
Matthew I. Milowsky, Peter H. O Donnell, Thomas W. Flaig, Dan Theodorescu

25 Neo–adjuvant Chemotherapy in the Treatment of Muscle–invasive Bladder Cancer
David I. Quinn, Cora N. Sternberg

26 Adjuvant Chemotherapy for Invasive Bladder Cancer
André P. Fay, Jeffrey J. Leow, Joaquim Bellmunt

27 Treatment of Metastatic Bladder Cancer
Gopa Iyer, Fabio Calabró, Dean F. Bajorin

28 Treatment of Poor Risk Patients
Maria De Santis, Matthew D. Galsky

Part VI: Genomics and the Current Status of Urothelial Cancer

29 Molecular Events in Muscle–invasive Bladder Cancer Development
Jonathan Rosenberg, William Y. Kim, Jaegil Kim, David J.Kwiatkowski

30 Cancer Stem Cells and Intrinsic Subtypes in Bladder Cancer
Keith Syson Chan, David J. McConkey

31 Multi–targeted Agents in Treatment of Urothelial Carcinoma
Noah M. Hahn, Colin P.N. Dinney, Guru Sonpavde

Part VII: Optimizing Health Care Delivery

32 Patient Navigation and Cancer Navigator Programs
Scott M. Gilbert, Michael Porter

33 Impact of Health Services on Compliance and Outcomes
Heather Honoré Goltz, Marc A. Kowalkowski, G. John Chen, David M. Latini

34 Quality of Life and Survivorship
Nihal E. Mohamed, Cheryl T. Lee

35 Bladder Cancer: Health Care Delivery and Third Party Payers
Seth A. Strope, John L. Gore

36 Bladder Cancer Patient Advocacy: Creating Partnerships to Advance Patient Care, Research, and Clinical Trials
Diane Zipursky Quale, Rick Bangs